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Background: Although human parainfluenza type 2 (HPIV-2) virus is an important respiratory pathogen, a little is
known about strains circulating in Saudi Arabia.
Findings: Among 180 nasopharyngeal aspirates collected from suspected cases in Riyadh, only one sample (0.56%)
was confirmed HPIV-2 positive by nested RT-PCR. The sample that was designated Riyadh 105/2009 was used for
sequencing and phylogenetic analysis of the most variable virus gene; the haemagglutinin-neuramindase (HN).
Comparison of HN gene of Riyadh 105/2009 strain and the relevant sequences available in GenBank revealed a
strong relationship with Oklahoma-94-2009 strain. Phylogenetic analysis indicated four different clusters of HPIV-2
strains (G1-4). Twenty-three amino acid substitutions were recorded for Riyadh 105/2009, from which four are
unique. The majority of substitutions (n=18) had changed their amino acids characteristics. By analyzing the effect
of the recorded substitutions on the protein function using SIFT program, only two located at positions 360
and 571 were predicted to be deleterious.
Conclusions: The presented changes of Riyadh 105/2009 strain may possess potential effect on the protein
structure and/or function level. This is the first report that describes partial characterization of Saudi HPIV-2 strain.
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Human parainfluenza type 2 virus (HPIV-2) is one of the
important viruses that infect the human respiratory tract
causing croup and pneumonia [1]. It is an enveloped non-
segmented negative single-stranded RNA virus that
belongs to genus Rubulavirus of the family Paramyxoviri-
dae. The virus genome is approximately 15 kb long and
encodes seven structural proteins. The nucleocapsid (N),
phosphoprotein (P), and large polymerase (L) encapsidate
the genomic RNA, while hemagglutinin-neuraminidase
(HN), fusion (F), and matrix (M) are envelope-associated
proteins [2].* Correspondence: majhdi@ksu.edu.sa
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reproduction in any medium, provided the orHN protein constitutes the prominent virus fringes re-
sponsible for binding to sialoconjugate receptors (hemag-
glutinating activity), and for enzymatic destruction of the
receptors (neuramindase activity). Moreover, the stalk
region of HN was proposed to contain the site which pro-
motes cell fusion by F protein [3,4]. Extensive genetic and
antigenic variations among HPIV-2 strains were attributed
to HN gene diversity [5,6]. Two distinct clusters were sug-
gested by phylogenetic analysis of HPIV-2 strains on the
basis of complete HN gene sequence. However, this phylo-
genetic tree was inadequately informative due to the low
number of analyzed sequences [5]. In this report, the
complete HN sequence of first Saudi HPIV-2 strain was
analyzed and compared to the corresponding sequences
available in GenBank. A phylogenetic tree was constructed
to determine the predictable origin of Saudi strain and the
relationship between different strains circulating globally.
Nasopharyngeal aspirates of 180 children, hospitalized
with acute respiratory disease in King Khalid Universityal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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Sample collection was approved by the Ethical Committee
of King Saud University. The aspirates were taken from
patients, after getting an informed consent from their
parents. Samples were chilled transported in Minimal
Essential Medium supplemented with 500 U penicillin
and 500 μg streptomycin per ml (Sigma, St. Louis, MO) to
Virology Research Laboratory, King Saud University. After
pulse-vortexing and centrifugation at 3000 rpm for 10
min, 140 μl aliquots of the clarified supernatants were uti-
lized for RNA extraction using QIAamp viral RNA extrac-
tion kit (Qiagen, Hilden, Germany) according to the
manufacturer`s guidelines. Detection of HPIV-2 RNA was
accomplished by amplification of 508 bp fragment of HN
gene using One-step RT-PCR kit (Qiagen) and the primer
set HPIV2-cDNA/HPIV2-rev (Table 1). Positive reactions
were confirmed by the amplification of an internal 204 bp
fragment of the PCR amplicon in a nested PCR using
TopTaq Master Mix Kit (Qiagen), and the primer set
HPIV2-nF/HPIV2-nR (Table 1). Products of both reactions
were analyzed, along with 100 bp DNA ladder (Qiagen), in
1.5% agarose gel stained with ethidium bromide.
Only one sample (0.56%), collected from two-year old
female child, was confirmed positive for HPIV-2. The
sample, designated Riyadh 105/2009, was used for se-
quencing and phylogenetic analysis of the complete HN
gene. Sequencing strategy involved the amplification of
three overlapping fragments, that flank the entire HN
gene sequence, using FideliTaq™ RT-PCR Master Mix
(GE Healthcare, Buckinghamshire, UK) and sequencing
primer sets (Table 1). Specific RT-PCR products were
purified from agarose gel using Illustra GFX PCR DNA
Kit (GE Healthcare), and were sequenced on both
strands (GenArt, Rosensburg, Germany). NucleotideTable 1 Oligonucleotide primers used in the study














a Nucleotide positions based on the complete genome sequence of HPIV-2 strain Gsequences were edited and assembled using Bioedit Bio-
logical Sequence Alignment Editor (Ibis Biosciences,
Carlsbad, CA). Complete nucleotide and deduced amino
acid sequences of HN gene of Riyadh 105/2009 strain
were deposited in GenBank under the accession number
HM460888. Multiple alignments with 17 HPIV-2
complete HN sequences available in GenBank (Table 2)
were performed using the Clustal W algorithm of Mega-
lign program, Lasergene software. Divergence analysis
and tree construction were conducted using the same
software, with 1,000 bootstrap replicates. The effect of
non-synonymous mutations on the protein function was
predicted using SIFT program (http://sift.bii.a-star.edu.
sg).
As expected, the results of sequence analysis revealed
a single ORF of 1716 nucleotides that encodes a poly-
peptide of 571 amino acids [8]. Multiple sequence com-
parisons between Riyadh 105/2009 strain and the
different global strains showed that the homology ranges
from 91.8% to 99.1% and from 93.9% to 99% on the
levels of nucleotide and deduced amino acids, respect-
ively. A close relationship between the Saudi strain and
Oklahoma-94-2009 strain (GenBank Accession number
JF912194) was observed with only 16 nucleotide (0.9%)
and 4 amino acid (0.7%) variations. This relationship
may propose a common ancestral origin of both viruses.
Seven unique nucleotide substitutions (0.41%) were
found in Riyadh 105/2009 strain (G53A, A54G, T143C,
T148C, T1327C, T1383, and G1401). As a result, four
amino acids (0.53%) at positions 18, 48, 50, and 443 were
changed.
Phylogenetic analysis of the different worldwide strains
of HPIV-2 indicated four different clusters (G1-4). Clus-







TAACGTC 6648-6672 886 bp
CAGC 7512-7533
TCACAATG 7348-7373 840 bp
ACTC 8166-8187
TCC 8137-8157 426 bp
CAATAG 8539-8562
reer; GenBank accession number AF533012.
Table 2 Amino acid differences among the selected HPIV-2 strains as compared to the Saudi strain Riyadh 105/2009
Straina Country/Year 18 48 50 54 57 67 114 139 164 175 195 201 319 332 344 345 351 360 367 376 443 482 571
Riyadh 105/2009b Saudi Arabia/2009 K A P N D V T K H S T A S T E R G Y I Q H Q P
86-391 Japan/2004 R V S D E I A E N I A S T K K Q S N V H Y R L
76-86 Japan/2004 R V S D E I A E N I A S T K K Q S N V H Y R L
4-80 Japan/2004 R V S D E I A E N I A S T K K Q S N V H Y R L
TC-6482 Japan/2004 R V S D E I A E N I A S T K K Q S N V H Y R L
TC-6558 Japan/2004 R V S D E I A E N I A S T K K Q S N V H Y R L
62-M786 Japan/2004 R V S D I N I Q N N V H Y
Greer-J1 Japan/2007 R V S D I N I K Q S N V H Y
Toshiba Japan/1990 R V S D I N I K Q S N V H Y
London UK/1990 R V S D I N I K Q S N V H Y
Lyon-26056-1997 France/1997 R V S D E I A E N I A S T K K Q N N V H Y R L
Lyon-18620-2001 France/2001 R V S E I A E I A S T K K Q S N V H Y R L
Lyon-20283-2001 France/2001 R V S E I A E I A S T K K Q S N V H Y R L
Lyon-20435-2001 France/2001 R V S E I A E I A S T K K Q S N V H Y R L
V9412-6 USA/1999 R V S E I A E I A S T K K Q S N V H Y R L
Oklahoma-94-2009 USA/2009 R V S Y
Oklahoma-283-2009 USA/2005 R V S E I A E I A S T K K Q S N V H Y R L
Oklahoma-3955-2005 USA/2005 R V S D E I A E N I A S T K K Q S N V H Y R L
a Accession numbers of the strains used in analysis –in order– are: Genbank HM460888, AB189949, AB189950, AB189951, AB189952, AB189953, AB189948, AB367954, X57559, D00865, DQ072589, DQ072586,
DQ072587, DQ072588, AF213352, JF912194, JF912195, and JF912196.















Figure 1 Phylogenetic analysis based on the complete HN gene
nucleotide sequence of the different HPIV-2 strains circulating
globally. Tree was constructed using Megalign program of
Lasergene software (DNASTAR) with 1000 bootstraps. HPIV-2 strains
included in the analysis were grouped in four clusters (G1-4). Each of
clusters G1 and G4 were split into two subclusters (a and b). Riyadh
105/2009 strain was indicated by a red frame, and was grouped
with Oklahoma-94-2009 strain in cluster G3. Scale bar indicates
number of nucleotide substitution per site.
Almajhdi et al. Virology Journal 2012, 9:316 Page 4 of 5
http://www.virologyj.com/content/9/1/316and b (Figure 1). Both Riyadh 105/2009 and Oklahoma-
94-2009 strains were grouped together in cluster G3. The
nucleotide and deduced amino acid sequence compari-
sons, between Riyadh 105/2009 strain and the different
strains of each group, further established this classification.
For instance, the homology between Riyadh 105/2009 and
G1 viruses ranged from 91.8-92.7% (nucleotides), and
93.9-94.8% (amino acids), while for G2 and G4 viruses, the
homology was 93–93.2%, and 96.2-96.4% on the nucleo-
tide level, and 95.1-95.3%, and 96–96.2% on the amino
acid level, respectively. This Phylogenetic differentiation
correlates well with the tree constructed by Terrier et al.
[5], in which two clusters were defined. The first cluster
included G1 and G2 strains of the conducted phylogram,
while the second contained strains of G4 cluster. G3 clus-
ter strains were not included in that study due to their re-
cent identification. It may be concluded that new variant
strains are continuing to emerge, and therefore, further
updating of this phylogram may be required upon identifi-
cation of more strains on spatial and temporal basis.
Analysis of the deduced amino acid sequence align-
ment identified 23 positions of potential variation be-
tween Riyadh 105/2009 and other international strains
(Table 2). Nineteen of these positions were shared with
the other G3 virus (Oklahoma-94-2009), while 9–10,
and 0–2 positions were only common with G4, and G1-
2 viruses, respectively. The majority of the recorded sub-
stitutions (n=18) changed the amino acid characteristics
on the level of charge, polarity, and/or hydropathy. How-
ever, the effect of these substitutions on the antigenic
properties of the mature HN protein could not be con-
cluded, since positions of the antigenic sites are not yetdetermined for HPIV-2. Aligning the positions of amino
acid substitution of Riyadh 105/2009 strain with their
counterparts in HPIV-3 HN protein identified a single
residue (Q345R) that may be located in a distinct anti-
genic site [9].
Studying the effect of amino acid change on the pro-
tein function using SIFT program [10], outlined that all
of the substitutions are well tolerated; except the change
of asparagine (N) to tyrosine (Y) at position 360, and
leucine (L) to proline (P) at position 571 that were pre-
dicted to affect the protein function with a score of 0.02
and 0.00, respectively. These two residues locate in the
globular head region that carries both haemagglutinating
and neutamindase activities [11]. However, the extent of
their effect on the protein function would be correctly
concluded when the three-dimensional structure of HN
protein becomes available, and the amino acids crucial
for both activities are determined.
In conclusion, the complete HN gene sequence of the
first HPIV-2 Saudi strain (Riyadh 105/2009) was ana-
lyzed and compared to the corresponding sequences/
strains at GenBank. Phylogenetic analysis of these strains
allowed allocation of four separate clusters G1-G4. Saudi
strain was more relevant to Oklahoma-94-2009 strain,
which may propose a common ancestral origin. The ma-
jority of the amino acid substitutions observed in Riyadh
105/2009 strain changed the properties of their respect-
ive amino acids. However, the effect of these substitu-
tions on the protein structure and function requires
more detailed studies.
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